Clinical Chemistry AACC Online Job Center
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Clinical Chemistry 39: 2146-2150, 1993;
This Article
Right arrow Full Text (PDF)
Right arrow Submit an electronic Letter to
the Editor about this paper
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kjems, L. L.
Right arrow Articles by Binder, C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kjems, L. L.
Right arrow Articles by Binder, C.

Clinical Chemistry, Vol 39, 2146-2150, Copyright © 1993 by American Association for Clinical Chemistry

Highly sensitive enzyme immunoassay of proinsulin immunoreactivity with use of two monoclonal antibodies

LL Kjems, ME Roder, B Dinesen, SG Hartling, PN Jorgensen and C Binder
Steno Diabetes Center, Gentofte, Denmark.

A highly sensitive two-site sandwich ELISA measuring total proinsulin immunoreactive material in serum or plasma was developed. The assay was based on two monoclonal antibodies, an anti-C-peptide antibody bound to a microtest plate and a biotin-labeled anti-insulin antibody. The detection limit (3 SD above zero value) in buffer was 0.05 pmol/L, corresponding to 0.25 pmol/L in human serum (diluted 1:5). The linear calibrator range was 0.05-20 pmol/L. Interassay CVs were 4.7% at a median (range) of 2.3 pmol/L (1.4-2.8 pmol/L, n = 8), 6.7% at 5.1 pmol/L (3.3-8.0 pmol/L, n = 8), and 8.7% at 10.0 pmol/L (8-12 pmol/L, n = 10). Mean analytical recovery of added human proinsulin (hPI) (2, 5, and 10 pmol/L) to serum was 84% (range 68-128%, n = 9). Human insulin and human C-peptide did not cross-react at 5000 and 10,000 pmol/L, respectively. The four major proinsulin conversion intermediates reacted 65-99%: split(32-33)hPI 74%, des-(31,32)hPI 65%, split(65- 66)hPI 78%, and des(64,65)hPI 99%. All serum values from 38 fasting healthy subjects were above the detection limit: median (range) 4.0 (2.1-12.6) pmol/L.


The following articles in journals at HighWire Press have cited this article:


Home page
 EndocrinologyHome page
S. H. Song, C. J. Rhodes, J. D. Veldhuis, and P. C. Butler
Diazoxide Attenuates Glucose-Induced Defects in First-Phase Insulin Release and Pulsatile Insulin Secretion in Human Islets
Endocrinology, August 1, 2003; 144(8): 3399 - 3405.
[Abstract] [Full Text] [PDF]

Home page
 Am J EpidemiolHome page
V. Grill, B. Dinesen, S. Carlsson, S. Efendic, O. Pedersen, and C.-G. Ostenson
Hyperproinsulinemia and Proinsulin-to-Insulin Ratios in Swedish Middle-aged Men: Association with Glycemia and Insulin Resistance but Not with Family History of Diabetes
Am. J. Epidemiol., May 1, 2002; 155(9): 834 - 841.
[Abstract] [Full Text] [PDF]

Home page
 StrokeHome page
B. Lindahl, B. Dinesen, M. Eliasson, M. Roder, G. Hallmans, and B. Stegmayr
High Proinsulin Levels Precede First-Ever Stroke in a Nondiabetic Population
Stroke, December 1, 2000; 31(12): 2936 - 2941.
[Abstract] [Full Text] [PDF]

Home page
 Arch. Dis. Child. Fetal Neonatal Ed.Home page
F. Ebbesen, A. Joergensen, E. Hoseth, P.-H. Kaad, M. Moeller, V. Holsteen, and M. Rix
Neonatal hypoglycaemia and withdrawal symptoms after exposure in utero to valproate
Arch. Dis. Child. Fetal Neonatal Ed., September 1, 2000; 83(2): 124F - 129.
[Abstract] [Full Text]

Home page
 Clin. Chem.Home page
P. Houssa, B. Dinesen, M. Deberg, B. H. Frank, C. Van Schravendijk, F. Sodoyez-Goffaux, and J.-C. Sodoyez
First direct assay for intact human proinsulin
Clin. Chem., July 1, 1998; 44(7): 1514 - 1519.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
A. D. Kippen, F. Cerini, L. Vadas, R. Stocklin, L. Vu, R. E. Offord, and K. Rose
Development of an Isotope Dilution Assay for Precise Determination of Insulin, C-peptide, and Proinsulin Levels in Non-diabetic and Type II Diabetic Individuals with Comparison to Immunoassay
J. Biol. Chem., May 9, 1997; 272(19): 12513 - 12522.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1993 by the American Association for Clinical Chemistry.